3SBioSTU:83B -3.65%90 Market Cap is €4,728 Mil as of Jul. 01, 2026. GuruFocus rates STU:83B with a GF Score™ of 90/100 and a GF Value™ of €1.52 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 1,428 Biotechnology companies, 3SBio ranks better than 94.54% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 3SBio's share price for the quarter that ended in Dec. 2025 was €2.68. 3SBio's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 2,501 Mil. Therefore, 3SBio's market cap for the quarter that ended in Dec. 2025 was €6,702 Mil.
3SBio's quarterly market cap
increased
from Dec. 2024 (€1,731 Mil) to Jun. 2025 (€5,851 Mil) and
increased
from Jun. 2025 (€5,851 Mil) to Dec. 2025 (€6,702 Mil).
3SBio's annual market cap
declined
from Dec. 2023 (€2,027 Mil) to Dec. 2024 (€1,731 Mil) but then
increased
from Dec. 2024 (€1,731 Mil) to Dec. 2025 (€6,702 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 3SBio's Enterprise Value for Today is €2,959 Mil.
3SBio (STU:83B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
3SBio Market Cap Related Terms
3SBio Market Cap Historical Data
* Premium members only.
The historical data trend for 3SBio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:83B vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, 3SBio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3SBio Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 3SBio's Market Cap distribution charts can be found below:
* The bar in red indicates where 3SBio's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
3SBio's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3SBio (STU:83B) has a Market Cap of €4,728 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 3SBio and its competitors. According to the industry distribution chart, 3SBio ranks #78 out of 1428 companies in the Biotechnology industry, placing it in the top 5.5%.
Is 3SBio's Market Cap too high?
3SBio's current Market Cap is €4,728 Mil. Based on the distribution chart, 3SBio ranks #78 out of 1428 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, 3SBio has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3SBio's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3SBio ranks #78 out of 1428 companies for Market Cap. This places 3SBio in the top 6% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.44, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 3SBio and its competitors. For the Biotechnology industry, the median Market Cap is 119.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 3SBio's current Market Cap is €4,728 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3SBio stock overvalued right now?
Based on GuruFocus' analysis, 3SBio (STU:83B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.52, compared to a current price of €1.84 — trading 20.7% above its estimated fair value. The current Market Cap is €4,728 Mil. 3SBio's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For 3SBio (STU:83B), the current Market Cap is €4,728 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3SBio (STU:83B) Overvalued in 2026?
Based on GuruFocus' analysis, 3SBio stock appears to be overvalued.
The current stock price of €1.84 is trading 20.7% above its estimated GF Value™ of €1.52.
GuruFocus considers 3SBio to be Modestly Overvalued.
Key valuation signals for STU:83B:
Market Cap: €4,728 Mil
GF Value™: €1.52 vs. price of €1.84 (20.7% above fair value)
No single metric tells the full story. See the STU:83B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
90GF Score
Get the complete analysis for STU:83B
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:83B has been successfully added to your 
